- 中文名称
Ep大鼠uzumab 生物类似药, 内毒素 0.05 EU/mg
- 英文名字
- Epratuzumab Biosimilar, Endotoxin 0.05 EU/mg
- 供应商
- Promab
- 产品货号
- PMB-B00039.05
- 产品报价
- ¥询价/5mg/20mg

- 产品说明书
- 点击查看
- 购买方式
- 90%产品中国有现货库存。银行转账、电汇、支票、现金,在线支付宝及网银支付,或直接与我们电话联系400-6800-868
- 产品新闻

- 背景资料
- Epratuzumab Biosimilar uses the same protein sequences as the therapeutic antibody epratuzumab.nnEpratuzumab is a humanized monoclonal antibody derived from the murine IG2a monoclonal antibody, LL2 (EPB-2). This agent may subsequently be well matched for use in oncology and the treatment of inflammatory autoimmune disorders, such as lupus.nnEpratuzumab is a recombinant, humanized monoclonal antibody directed against CD22, a cell surface glycoprotein present on mature B-cells and on many types of malignant B-cells. It binds with high specificity to normal B-cells and B-cell tumors at the third Ig-like domain of CD22. After binding to CD22, epratuzumab's predominant antitumor activity appears to be mediated through antibody-dependent cellular cytotoxicity (ADCC).
- 应用类型
- Flow cytometry, animal model study
- 免疫原
- Human CD22
- 来源宿主
- CHO cells
- 反应性
- Human
- 保存建议
- Store at 4°C 1 month, store at -20°C to -70°C 12 month. protected from prolonged exposure to light. Avoid freeze/thaw cycles.
- 其他
- cluster of differentiation-22, SIGLEC-2, SIGLEC2

- 注意
-
该页面的中文产品信息的翻译,仅供参考。准确的产品信息请以厂家的英文说明书为准。下单前,请浏览说明书确认。
-